Talaris Therapeutics, Inc. (TALS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 68.95M |
| Enterprise Value | 38.68M |
| P/E Ratio | -18.09 |
| PEG Ratio | 0.53 |
| Price/Sales Ratio | 30,816.28 |
| Price/Book Ratio | 4.77 |
| Enterprise/Revenue | 30,034.33 |
| Enterprise/EBITDA | -16.88 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | -1,707.43 |
| Operating Margin | -1,950.28 |
| Return On Assets | -0.25 |
| Return On Equity | -0.24 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 39,000 |
| Net Income | -73.21M |
| Diluted EPS | -2.89 |
| Total Cash | 239.23M |
| Total Cash/Share | 9.29 |
| Total Debt | 145,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 24.68 |
| Book Value Per Share | 10.06 |
| 52-Week Change | 91.55 |
| 52-Week High | 3.29 |
| 52-Week Low | 0.89 |
| Moving Average 50 Days | 2.83 |
| Moving Average 200 Days | 2.44 |
| Average Volume | 142,922 |
| Shares Outstanding | 42.81M |
| % Held by Institutions | 65.07 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | October 20, 2023 |